ArticleThe Journal of pharmacology and experimental therapeutics2011

The soluble guanylate cyclase stimulator BAY 41-2272 inhibits vascular smooth muscle growth through the cAMP-dependent protein kinase and cGMP-dependent protein kinase pathways.

Chintamani N Joshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.